A NEW GENERATION OF IMMUNOTHERAPIES
Board of Directors
Suchi Acharya, PhD
Board Chairman
Dr. Suchismita Acharya is the Founding President of AyuVis Research. Prior to AyuVis, She spent 15 years in various leadership roles with Alcon Labs (Novartis) and led projects from early stage to pre-clinical in glaucoma, AMD and anti-viral diseases.
She is an innovative scientist with the ambition of adding first in-class small molecules for ocular as well as anti bacterial/viral diseases to AyuVis’ research and drug discovery portfolio. She is a certified Project Manager and managed drug discovery projects from hit to lead, lead optimization and lead the project through phase-I-III clinical trials in humans.
Stella Robertson, PhD
Board Secretary
Dr Stella Robertson has over 25 years of experience in pharmaceutical Research and Development, including R&D strategies, project management, clinical trials, regulatory filings for US and international registrations, product launch, market support, translational medicine and medical communication.
She formerly was a Vice President in Research and Development at Alcon Laboratories, Inc., a Division of Novartis, where she grew and led organizations that were responsible for the ophthalmic pipeline, otic pharmaceuticals, and medical devices. She is a Ph.D. in Biology-Immunology from Johns Hopkins University, is an adjunct member of the Ophthalmology Department of UTHSCD Southwestern Medical School, and a volunteer in the University of North Texas Health Science Center translational research and entrepreneurial program. She holds a number of patents and is the author or co-author of over 50 publications.
Stella is also a Drug Development Advisor for AyuVis Research.
Gagan Acharya
Board Member
Gagan Acharya is the co-founder of AyuVis Research. He is a Chartered Accountant and an experienced IT professional with excellent knowledge over finance, accounting and business.
He has 20+ years of experience as a technology executive, in healthcare, investment, and mortgage industries.